(ALV) Autoliv - Overview
Sector: Consumer Cyclical | Industry: Auto Parts | Exchange: NYSE (USA) | Market Cap: 8.823m USD | Total Return: 21.6% in 12m
Avg Turnover: 81.1M
EPS Trend: 83.0%
Qual. Beats: -1
Rev. Trend: 77.9%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Autoliv, Inc. (ALV) is a Sweden-based manufacturer specializing in passive safety systems for the global automotive industry. The company develops and supplies critical components including airbag modules, seatbelts, steering wheels, and pedestrian protection systems to major vehicle manufacturers across the Americas, Europe, and Asia.
Operating within the Automotive Parts & Equipment sub-industry, Autoliv functions as a Tier 1 supplier, meaning it maintains direct relationships with Original Equipment Manufacturers (OEMs) and integrates its products early in the vehicle design phase. The sector is characterized by high barriers to entry due to stringent safety regulations and the capital-intensive nature of crash-test engineering and inflator technology production.
Beyond passenger cars, the company has expanded its business model to include mobility safety solutions for commercial vehicles, motorcycles, and bicycles. Investors may find it useful to examine ValueRay for deeper insights into the companys valuation and market positioning. Founded in 1953, Autoliv remains a dominant player in the global safety market, leveraging its extensive patent portfolio and manufacturing footprint to maintain its competitive standing.
- Global light vehicle production volumes dictate primary revenue and order book growth
- Rising raw material costs and energy inflation pressure quarterly operating margins
- Expansion of automotive safety regulations in emerging markets boosts content per vehicle
- Implementation of strategic footprint optimization and headcount reductions improves cost structure
- Market share gains in China bolster geographic diversification and revenue stability
| Net Income: 710.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 1.02 > 1.0 |
| NWC/Revenue: 2.54% < 20% (prev -0.98%; Δ 3.51% < -1%) |
| CFO/TA 0.12 > 3% & CFO 1.00b > Net Income 710.0m |
| Net Debt (2.07b) to EBITDA (1.50b): 1.38 < 3 |
| Current Ratio: 1.08 > 1.5 & < 3 |
| Outstanding Shares: last quarter (75.1m) vs 12m ago -3.59% < -2% |
| Gross Margin: 19.30% > 18% (prev 0.19%; Δ 1.91k% > 0.5%) |
| Asset Turnover: 132.6% > 50% (prev 127.6%; Δ 4.95% > 0%) |
| Interest Coverage Ratio: 10.43 > 6 (EBITDA TTM 1.50b / Interest Expense TTM 104.0m) |
| A: 0.03 (Total Current Assets 3.99b - Total Current Liabilities 3.71b) / Total Assets 8.47b |
| B: 0.28 (Retained Earnings 2.38b / Total Assets 8.47b) |
| C: 0.13 (EBIT TTM 1.08b / Avg Total Assets 8.29b) |
| D: 0.33 (Book Value of Equity 1.92b / Total Liabilities 5.82b) |
| Altman-Z'' = 2.36 = BBB |
| DSRI: 1.03 (Receivables 2.42b/2.21b, Revenue 11.0b/10.4b) |
| GMI: 0.98 (GM 19.30% / 18.97%) |
| AQI: 0.94 (AQ_t 0.23 / AQ_t-1 0.24) |
| SGI: 1.06 (Revenue 11.0b / 10.4b) |
| TATA: -0.03 (NI 710.0m - CFO 1.00b) / TA 8.47b) |
| Beneish M = -3.04 (Cap -4..+1) = AA |
As of May 25, 2026, the stock is trading at USD 122.73 with a total of 440,762 shares traded.
Over the past week, the price has changed by +7.67%,
over one month by +4.97%,
over three months by +0.96% and
over the past year by +21.55%.
Autoliv has received a consensus analysts rating of 4.06. Therefore, it is recommended to buy ALV.
- StrongBuy: 7
- Buy: 5
- Hold: 6
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 132.2 | 7.7% |
P/E Trailing = 12.6868
P/E Forward = 10.9649
P/S = 0.8029
P/B = 3.2842
P/EG = 0.8491
Revenue TTM = 11.0b USD
EBIT TTM = 1.08b USD
EBITDA TTM = 1.50b USD
Long Term Debt = 1.70b USD (from longTermDebt, last quarter)
Short Term Debt = 436.0m USD (from shortTermDebt, last quarter)
Debt = 2.41b USD (from shortLongTermDebtTotal, last quarter) + Leases 160.0m
Net Debt = 2.07b USD (calculated: Debt 2.41b - CCE 342.0m)
Enterprise Value = 10.9b USD (8.82b + Debt 2.41b - CCE 342.0m)
Interest Coverage Ratio = 10.43 (Ebit TTM 1.08b / Interest Expense TTM 104.0m)
EV/FCF = 18.81x (Enterprise Value 10.9b / FCF TTM 579.0m)
FCF Yield = 5.32% (FCF TTM 579.0m / Enterprise Value 10.9b)
FCF Margin = 5.27% (FCF TTM 579.0m / Revenue TTM 11.0b)
Net Margin = 6.46% (Net Income TTM 710.0m / Revenue TTM 11.0b)
Gross Margin = 19.30% ((Revenue TTM 11.0b - Cost of Revenue TTM 8.87b) / Revenue TTM)
Gross Margin QoQ = 19.11% (prev 20.31%)
Tobins Q-Ratio = 1.29 (Enterprise Value 10.9b / Total Assets 8.47b)
Interest Expense / Debt = 4.31% (Interest Expense 104.0m / Debt 2.41b)
Taxrate = 29.70% (60.0m / 202.0m)
NOPAT = 762.7m (EBIT 1.08b * (1 - 29.70%))
Current Ratio = 1.08 (Total Current Assets 3.99b / Total Current Liabilities 3.71b)
Debt / Equity = 0.92 (Debt 2.41b / totalStockholderEquity, last quarter 2.63b)
Debt / EBITDA = 1.38 (Net Debt 2.07b / EBITDA 1.50b)
Debt / FCF = 3.58 (Net Debt 2.07b / FCF TTM 579.0m)
Total Stockholder Equity = 2.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.56% (Net Income 710.0m / Total Assets 8.47b)
RoE = 27.78% (Net Income TTM 710.0m / Total Stockholder Equity 2.56b)
RoCE = 25.50% (EBIT 1.08b / Capital Employed (Equity 2.56b + L.T.Debt 1.70b))
RoIC = 15.71% (NOPAT 762.7m / Invested Capital 4.85b)
WACC = 8.02% (E(8.82b)/V(11.2b) * Re(9.38%) + D(2.41b)/V(11.2b) * Rd(4.31%) * (1-Tc(0.30)))
Discount Rate = 9.38% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.56 | Cagr: -4.70%
[DCF] Terminal Value 77.97% ; FCFF base≈536.2m ; Y1≈614.7m ; Y5≈904.6m
[DCF] Fair Price = 154.2 (EV 13.6b - Net Debt 2.07b = Equity 11.5b / Shares 74.9m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 82.96 | EPS CAGR: 16.43% | SUE: -1.30 | # QB: -1
Revenue Correlation: 77.86 | Revenue CAGR: 2.70% | SUE: 1.75 | # QB: 1
EPS current Quarter (2026-06-30): EPS=2.38 | Chg30d=-2.03% | Revisions=-17% | Analysts=9
EPS next Quarter (2026-09-30): EPS=2.67 | Chg30d=-1.60% | Revisions=-33% | Analysts=9
EPS current Year (2026-12-31): EPS=10.48 | Chg30d=-0.64% | Revisions=-29% | GrowthEPS=+6.4% | GrowthRev=+2.7%
EPS next Year (2027-12-31): EPS=11.95 | Chg30d=-0.17% | Revisions=-38% | GrowthEPS=+14.0% | GrowthRev=+3.1%
[Analyst] Revisions Ratio: -38%